Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

Responding to criticism from scientists, physicians and patients, the CDC made minimal and meaningless changes to the guidelines in 2022. Health practitioners who deviate from these ...

The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming ...

Both the CDC and ... out with the influenza recommendation in a timely manner,” Dr. Paul Offit, a member of the independent advisory committee and director of the Vaccine Education Center ...